Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01533948
Title Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed By Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

melanoma

Therapies

Axitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.